Chemocentryx Inc. buy PlusUltra
Start price
17.10.21
/
0%
€29.43
Target price
17.10.22
-
Performance (%)
72.85%
End price
15.09.22
€50.87
Summary
This prediction ended on 15.09.22 with a price of €50.87. With a performance of 72.85% the BUY prediction by PlusUltra was a big success. This prediction was marked as speculative and is excluded from PlusUltra's performance statistics.Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Chemocentryx Inc. | - | - | - | - |
| iShares Core DAX® | 1,84 % | 1,39 % | 8,65 % | 62,63 % |
| iShares Nasdaq 100 | 4,66 % | -1,80 % | 27,82 % | 85,63 % |
| iShares Nikkei 225® | 3,96 % | -5,22 % | 51,81 % | 76,25 % |
| iShares S&P 500 | 3,70 % | 1,58 % | 24,09 % | 69,87 % |
According to PlusUltra what are the pros and cons of Chemocentryx Inc. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Capable Management
Innovative
Top 10 in its market
Cons
Comments by PlusUltra for this prediction
In the thread Discuss Chemocentryx Inc.
Buy Chemocentryx Inc.